• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.95% Nasdaq Down 2.40%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    504.97 Down 15.66(3.01%) Jun 29, 4:00PM EDT
    Add to Portfolio
    Prev Close:520.63
    Open:514.59
    Bid:475.01 x 200
    Ask:534.03 x 100
    1y Target Est:511.71
    Beta:0.71
    Earnings Date:Aug 3 - Aug 7 (Est.)
    Day's Range:504.52 - 520.50
    52wk Range:285.06 - 544.00
    Volume:600,676
    Avg Vol (3m):776,253
    Market Cap:53.15B
    P/E (ttm):162.01
    EPS (ttm):3.12
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for REGN

    Comparison

    Symbol% ChgMkt Cap
    REGNDown 3.01%53.15B
    AMGNDown 4.06%115.27B
    NVSDown 1.39%238.48B
    RHHBYDown 2.31%N/A

    Key Statistics

    Forward P/E (1 yr):37.54
    P/S (ttm):17.37
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :11.17
    Quarterly EPS Est (Jun-15) :2.78
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):2.33

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback